Benefit-to-risk ratio: the challenge of antibiotic drug resistance.
Slavkin
H C
HC
National Institute of Dental Research, Bethesda, Md. 20892-2290, USA.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D018570:Risk Assessment
D000900:Anti-Bacterial Agents